GODISC Trademark

Trademark Overview


On Tuesday, July 26, 2022, a trademark application was filed for GODISC with the United States Patent and Trademark Office. The USPTO has given the GODISC trademark a serial number of 97520313. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, April 8, 2024. This trademark is owned by CSL Behring AG. The GODISC trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations and substances for immunoglobulin therapy, the treatment or prevention of primary or secondary immunodeficiencies, autoimmune disease and disorders, blood and/or bleeding disorders and diseases; Pharmaceuticals for the treatment or prevention of blood and/or bleeding disorders; Blood products, namely, blood plasma and blood for medical or therapeutic purposes; Blood products, namely, immunoglobulins for medical and therapeutic purposes; Blood proteins for therapeutic use

Surgical and medical apparatus and instruments for the administration of subcutaneous therapy; Medical devices for the administration of subcutaneous therapy
godisc

General Information


Serial Number97520313
Word MarkGODISC
Filing DateTuesday, July 26, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, April 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for immunoglobulin therapy, the treatment or prevention of primary or secondary immunodeficiencies, autoimmune disease and disorders, blood and/or bleeding disorders and diseases; Pharmaceuticals for the treatment or prevention of blood and/or bleeding disorders; Blood products, namely, blood plasma and blood for medical or therapeutic purposes; Blood products, namely, immunoglobulins for medical and therapeutic purposes; Blood proteins for therapeutic use
Pseudo MarkGO DISC
Goods and ServicesSurgical and medical apparatus and instruments for the administration of subcutaneous therapy; Medical devices for the administration of subcutaneous therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, August 17, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBern CH-3000
CH

Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBern CH-3000
CH

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2024SOU EXTENSION 1 GRANTED
Monday, April 8, 2024SOU EXTENSION 1 FILED
Monday, April 8, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 24, 2023NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, April 24, 2023PRIORITY ACTION E-MAILED
Monday, April 24, 2023PRIORITY ACTION WRITTEN
Wednesday, April 12, 2023ASSIGNED TO EXAMINER
Wednesday, August 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 29, 2022NEW APPLICATION ENTERED